Blood pressure medicine after heart valve replacement for thickened heart muscle
Part of Heart & circulation clinical trials.
This trial tests whether a common blood pressure pill (called an angiotensin receptor blocker) can help your heart recover after a TAVR procedure. If you recently had TAVR for severe aortic stenosis and your heart muscle is thickened, this medicine might improve your long-term heart health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You had a TAVR procedure within the last month and it went well.
- You have severe aortic stenosis (a narrowed heart valve) and a thickened heart muscle.
- Your heart's pumping ability is still above 40%.
- You do not have serious kidney disease, low blood pressure, or high potassium levels.
- You have not had a heart attack in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares aspirin and clopidogrel (two blood-thinning medicines) after TAVR to see which is safer or more effective for preventing clots. You may be able to join if you recently had a TAVR for severe aortic valve narrowing and can follow the study plan.
This trial compares two blood thinners (ticagrelor and aspirin) to see which one works better at preventing blood clots after a less-invasive heart valve replacement (TAVI). It is for people with severe aortic stenosis who also have diabetes, heart disease, or artery disease.
This study tests a new replacement valve for the aortic heart valve, delivered through a catheter (a thin tube) — a procedure called TAVR. It is for people who have severe aortic stenosis and are not good candidates for open-heart surgery.
This trial compares different methods to evaluate coronary artery disease in patients planning to have a transcatheter aortic valve replacement (TAVR) for severe aortic stenosis. The goal is to find out if a less invasive approach is as safe and effective as the standard one.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This study looks at how well the new heart valve works after a TAVI procedure, using pressure measurements to see if blood flow improves. It aims to confirm that the treatment is effective for people with severe aortic stenosis.
Hear when a new Left Ventricular Hypertrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.